SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:146086122"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:146086122" > Comparative Assessm...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Comparative Assessment of the Pharmacovigilance Systems within the Neglected Tropical Diseases Programs in East Africa-Ethiopia, Kenya, Rwanda, and Tanzania

Barry, A (author)
Karolinska Institutet
Olsson, S (author)
Khaemba, C (author)
show more...
Kabatende, J (author)
Dires, T (author)
Fimbo, A (author)
Karolinska Institutet
Minzi, O (author)
Bienvenu, E (author)
Makonnen, E (author)
Kamuhabwa, A (author)
Oluka, M (author)
Guantai, A (author)
van Puijenbroek, E (author)
Bergman, U (author)
Karolinska Institutet
Nkayamba, A (author)
Mugisha, M (author)
Gurumurthy, P (author)
Aklillu, E (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2021-02-17
2021
English.
In: International journal of environmental research and public health. - : MDPI AG. - 1660-4601. ; 18:4
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Monitoring the safety of medicines used in public health programs (PHPs), including the neglected tropical diseases (NTD) program, is a WHO recommendation, and requires a well-established and robust pharmacovigilance system. The objective of this study was to assess the pharmacovigilance systems within the NTD programs in Ethiopia, Kenya, Rwanda, and Tanzania. The East African Community Harmonized Pharmacovigilance Indicators tool for PHPs was used to interview the staff of the national NTD programs. Data on four components, (i) systems, structures, and stakeholder coordination; (ii) data management and signal generation; (iii) risk assessment and evaluation; and (iv) risk management and communication, were collected and analyzed. The NTD programs in the four countries had a strategic master plan, with pharmacovigilance components and mechanisms to disseminate pharmacovigilance information. However, zero individual case safety reports were received in the last 12 months (2017/2018). There was either limited or no collaboration between the NTD programs and their respective national pharmacovigilance centers. None of the NTD programs had a specific budget for pharmacovigilance. The NTD program in all four countries had some safety monitoring elements. However, key elements, such as the reporting of adverse events, collaboration with national pharmacovigilance centers, and budget for pharmacovigilance activity, were limited/missing.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view